Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Ling Chang

Showing results (31-40 of 154) with videos related to

Pageof 16
Sort By:
Journal of Clinical and Translational Hepatology|February 12, 2024
Hepatocellular Carcinoma with Gastric Metastasis Mimicking a 4 cm Gastrointestinal Stromal Tumor After a 3-year Disease-free IntervalWei-Ting Chen, Shiu-Feng Kathy Huang, Ming-Ling Chang, et al.
Experimental and Therapeutic Medicine|October 12, 2019
Effect of HCV treatment response on insulin resistance: A systematic review and meta-analysisJing-Hong Hu, Ming-Ling Chang, Nai-Jen Liu, et al.
Scientific Reports|June 8, 2017
Retinol-binding protein-4 expression marks the short-term mortality of critically ill patients with underlying liver disease: Lipid, but not glucose, mattersWei-Ting Chen, Mu-Shien Lee, Chia-Lin Chang, et al.
Microbiology Spectrum|June 24, 2025
HCV Ab titer and ALT level indicate occult hepatitis C virus infection in treatment-naive HCV Ab-positive and HCV Ab-negative patients: a 3-year prospective cohort studyMing-Ling Chang, Wei-Ting Chen, Li-Heng Pao, et al.
Virulence|March 8, 2017
The evolving relationship between adiponectin and insulin sensitivity in hepatitis C patients during viral clearanceMing-Ling Chang, Chia-Jung Kuo, Li-Heng Pao, et al.
Biomedicines|May 27, 2026
Association Between SGLT2 Inhibitor Use and Hepatocellular Carcinoma Risk in Type 2 Diabetes: A Systematic Review and Meta-AnalysisJing-Hong Hu, Ming-Ling Chang, Tung-Jung Huang, et al.
Hepatology International|June 14, 2022
Comparable outcomes of decompensated chronic hepatitis B patients treated with entecavir or tenofovir: an 8-year cohort studyKuan-Chieh Lee, Jur-Shan Cheng, Ming-Ling Chang, et al.
Journal of Medical Virology|July 24, 2009
293 cells over-expressing human ADI1 and CD81 are permissive for serum-derived hepatitis C virus infectionJu-Chien Cheng, Yung-Ju Yeh, Li-Mei Pai, et al.
Viruses|February 27, 2026
Effect of Direct-Acting Antiviral Therapy on Glycemic Control in Patients with Chronic Hepatitis C and Type 2 Diabetes: A Systematic Review and Meta-AnalysisJing-Hong Hu, Ming-Ling Chang, Ming-Shyan Lin, et al.
Plos One|November 22, 2016
Association between Leptin and Complement in Hepatitis C Patients with Viral Clearance: Homeostasis of Metabolism and ImmunityMing-Ling Chang, Chia-Jung Kuo, Hsin-Chih Huang, et al.
Pageof 16

Showing results (31-40 of 154) with videos related to

Sort By:
Pageof 16
Journal of Clinical and Translational Hepatology|February 12, 2024
Hepatocellular Carcinoma with Gastric Metastasis Mimicking a 4 cm Gastrointestinal Stromal Tumor After a 3-year Disease-free IntervalWei-Ting Chen, Shiu-Feng Kathy Huang, Ming-Ling Chang, et al.
Experimental and Therapeutic Medicine|October 12, 2019
Effect of HCV treatment response on insulin resistance: A systematic review and meta-analysisJing-Hong Hu, Ming-Ling Chang, Nai-Jen Liu, et al.
Scientific Reports|June 8, 2017
Retinol-binding protein-4 expression marks the short-term mortality of critically ill patients with underlying liver disease: Lipid, but not glucose, mattersWei-Ting Chen, Mu-Shien Lee, Chia-Lin Chang, et al.
Microbiology Spectrum|June 24, 2025
HCV Ab titer and ALT level indicate occult hepatitis C virus infection in treatment-naive HCV Ab-positive and HCV Ab-negative patients: a 3-year prospective cohort studyMing-Ling Chang, Wei-Ting Chen, Li-Heng Pao, et al.
Virulence|March 8, 2017
The evolving relationship between adiponectin and insulin sensitivity in hepatitis C patients during viral clearanceMing-Ling Chang, Chia-Jung Kuo, Li-Heng Pao, et al.
Biomedicines|May 27, 2026
Association Between SGLT2 Inhibitor Use and Hepatocellular Carcinoma Risk in Type 2 Diabetes: A Systematic Review and Meta-AnalysisJing-Hong Hu, Ming-Ling Chang, Tung-Jung Huang, et al.
Hepatology International|June 14, 2022
Comparable outcomes of decompensated chronic hepatitis B patients treated with entecavir or tenofovir: an 8-year cohort studyKuan-Chieh Lee, Jur-Shan Cheng, Ming-Ling Chang, et al.
Journal of Medical Virology|July 24, 2009
293 cells over-expressing human ADI1 and CD81 are permissive for serum-derived hepatitis C virus infectionJu-Chien Cheng, Yung-Ju Yeh, Li-Mei Pai, et al.
Viruses|February 27, 2026
Effect of Direct-Acting Antiviral Therapy on Glycemic Control in Patients with Chronic Hepatitis C and Type 2 Diabetes: A Systematic Review and Meta-AnalysisJing-Hong Hu, Ming-Ling Chang, Ming-Shyan Lin, et al.
Plos One|November 22, 2016
Association between Leptin and Complement in Hepatitis C Patients with Viral Clearance: Homeostasis of Metabolism and ImmunityMing-Ling Chang, Chia-Jung Kuo, Hsin-Chih Huang, et al.
Pageof 16